Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05099705 · ClinicalTrials.gov registry record · NA
Testing a Family Service Navigator Program for Low-resourced Families of Young Children with Autism Spectrum Disorder
A NA study of Autism Spectrum Disorder and Mental Health Services, sponsored by Vanderbilt University.
- Active
- Registry status
- NA
- Development phase
- 55
- Enrollment target
- 1
- Study location
NCT05099705: Active NA study of Autism Spectrum Disorder and Mental Health Services, sponsored by Vanderbilt University.
NCT05099705 is a NA study of Autism Spectrum Disorder and Mental Health Services that is active but no longer recruiting, run by Vanderbilt University. The registered enrollment target is 55 participants, below the 135-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (59% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05099705, a NA study of Autism Spectrum Disorder and Mental Health Services, is active but no longer recruiting, sponsored by Vanderbilt University.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 55 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to develop and test a family navigator training and an app (a technology-based treatment support system) for low-resourced families of young children (aged 3-5) with autism. The hypothesis is that the navigator training and treatment support system will help enable navigators to support families of young children with autism in accessing needed services.
Primary Outcome
Called the Autism Knowledge Scale, a multi-item measure examining knowledge of autism services. There are 24 items with higher scores indicating more knowledge. Scale ranges from 0-24.
Conditions Studied
Interventions
- BEHAVIORAL Access to a Family Service Navigator and Treatment Support System
Study Locations (1)
Illinois
- University of Illinois at Urbana-Champaign - Champaign
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 55 participants |
| Start Date | 2022-07-01 |
| Est. Completion | 2026-04-30 |
| Phase | NA |
What the registry record for NCT05099705 still lists
NCT05099705 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 55 participants, a relatively small participant target, below the 135-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (59% lower).
The record links to 2 conditions, with Autism Spectrum Disorder appearing as the primary indexed condition, and to 1 intervention - of which Access to a Family Service Navigator and Treatment Support System is the first listed.
NCT05099705 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT05099705 about?
NCT05099705 is a clinical study titled "Testing a Family Service Navigator Program for Low-resourced Families of Young Children with Autism Spectrum Disorder". The purpose of this study is to develop and test a family navigator training and an app (a technology-based treatment support system) for low-resourced families of young children (aged 3-5) with autism. The hypothesis is that the navigator training and treatment support system will help enable navig...
What is the current status of trial NCT05099705?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 55 participants. The study started on 2022-07-01. Estimated completion is 2026-04-30.
What conditions does trial NCT05099705 study?
This clinical trial studies the following conditions: Autism Spectrum Disorder, Mental Health Services.
What interventions are being tested in trial NCT05099705?
The interventions under investigation include: Access to a Family Service Navigator and Treatment Support System (BEHAVIORAL).
Who is sponsoring clinical trial NCT05099705?
This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05099705 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Autism Spectrum Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05099705's enrollment target sits among peer trials
55 137th of 224 higher than 87 of 224 other Autism Spectrum Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Autism Spectrum Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
COMPASS Across Settings (CAST) for Improving Transition Outcomes for Students With ASD
RECRUITING · NA
-
Emergent Multi-Class Imitation Training
RECRUITING · NA
-
Physical Activity and Community EmPOWERment Project
RECRUITING · NA
-
Online Pivotal Response Treatment Training in Autism Spectrum Disorder
RECRUITING · NA
-
Cerebellum and Autism: Regional Specialization for Social and Executive Functions
RECRUITING · NA
-
Milieu Teaching-AV (MT-AV Pilot)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01638676 · 55 participants · Phase 1
A Phase I/II Trial of Vemurafenib and Metformin to Melanoma Patients
- NCT01906385 · 55 participants · Phase 1
Maximum Tolerated Dose, Safety, and Efficacy of Rhenium Nanoliposomes in Recurrent Glioma (ReSPECT)
- NCT03007030 · 55 participants · Phase 2
Brentuximab Vedotin in Treating Patients With CD30+ Malignant Mesothelioma That Cannot Be Removed by Surgery
- NCT03152058 · 55 participants · Phase 2
IMPACT Study: IMProve Pregnancy in APS With Certolizumab Therapy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI